Good start- HREC Approval: Getting approval from the Human Research Ethics Committee (HREC) is a critical step in clinical development. The first-in-human clinical trial for a drug is always a major milestone. The fact that Nyrada is advancing NYR-BI03 into Phase Ia shows progress from preclinical work to human trials. partnership with Scientia Clinical Research and Southern Star Research.
Still early days just a beginning The first readout will only come in Q3 2025.
MR Market - how do you plan to react to this news?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.015(4.23%) |
Mkt cap ! $78.03M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 36.0¢ | $244.1K | 667.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4705 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 597241 | 3 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |